Erectile Dysfunction clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • EndoPAT Device for Endothelial Dysfunction in ED

    open to eligible males ages 18 years and up

    To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy

    at UC Irvine

  • IT Matters: The Erectile Restoration Registry

    Sorry, accepting new patients by invitation only

    The objective of the It MATTERS registry is to collect Real-World Data (RWD) to monitor the safe and effective use of commercially available Boston Scientific Corporation (BSC) penile prostheses

    at UCLA

Last updated: